Beneficient
NASDAQ Global MarketTotal Valuation
Beneficient carries a market capitalization of 14.41M, placing it among publicly traded companies globally. Its enterprise value stands at 260.45M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 14.41M |
| Enterprise Value | 260.45M |
Share Statistics
Beneficient currently has 14.80M shares outstanding.
| Shares Outstanding | 14.80M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
Beneficient trades at a trailing price-to-earnings ratio of 2.16. The price-to-sales ratio is -2.77, and the price-to-book ratio stands at -0.26.
| PE Ratio | 2.16 |
| PS Ratio | -2.77 |
| PB Ratio | -0.26 |
| P/TBV Ratio | -0.25 |
| P/FCF Ratio | -1.24 |
| P/OCF Ratio | -1.24 |
Enterprise Valuation
| EV / Sales | N/A |
| EV / EBITDA | N/A |
| EV / EBIT | N/A |
| EV / FCF | 18.41 |
Financial Position
Beneficient maintains a current ratio of 0.12, meaning it holds 0.1x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -103.44, indicating conservative leverage, while an interest coverage ratio of -2.53 demonstrates limited ability to service its debt obligations.
| Current Ratio | 0.12 |
| Quick Ratio | 0.12 |
| Debt / Equity | -103.44 |
| Debt / EBITDA | -1.91 |
| Interest Coverage | -2.53 |
Financial Efficiency
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | -23.22 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | 95.15 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Taxes
| Income Tax | 214,000.00 |
| Effective Tax Rate | N/A |
Stock Price Statistics
Beneficient's stock has declined approximately -77.96454% over the past 52 weeks. The 50-day moving average sits at 1.62, while the 200-day moving average is 3.25.
| Beta (5Y) | N/A |
| 52-Week Price Change | -77.96454% |
| 50-Day Moving Average | 1.62 |
| 200-Day Moving Average | 3.25 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Beneficient generated -14.34M in revenue and converted that into -29.13M in net income, yielding earnings per share of -6.71. EBITDA reached -50.56M, while operating income came in at -51.18M.
| Revenue | -14.34M |
| Gross Profit | -25.68M |
| Operating Income | -51.18M |
| Pretax Income | -72.24M |
| Net Income | -29.13M |
| EBITDA | -50.56M |
| EBIT | -51.18M |
| Earnings Per Share (EPS) | -6.71 |
Balance Sheet
Beneficient holds 7.63M in cash and equivalents against 96.78M in total debt, resulting in a net debt position of 91.20M. Total book value stands at -210.40M, with working capital of -53.58M providing operational flexibility.
| Cash & Cash Equivalents | 7.63M |
| Total Debt | 96.78M |
| Net Debt | 91.20M |
| Equity (Book Value) | -210.40M |
| Book Value Per Share | -14.22 |
| Working Capital | -53.58M |
Cash Flow
Beneficient produced -31.99M in operating cash flow over the past twelve months.
| Operating Cash Flow | -31.99M |
| Capital Expenditures | N/A |
| Free Cash Flow | -31.99M |
| FCF Per Share | -2.96 |
Margins
Beneficient operates with a gross margin of 179.10, reflecting its pricing power and cost economics. The operating margin of 357.01 and net profit margin of 203.20 provide insight into operational efficiency.
| Gross Margin | 179.10 |
| Operating Margin | 357.01 |
| Pretax Margin | 503.91 |
| Profit Margin | 203.20 |
| EBITDA Margin | 352.63 |
Dividends & Yields
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | 21.50 |
| FCF Yield | -80.54 |
Stock Splits
Beneficient's most recent stock split took place on December 15, 2025 with a 8:1 split ratio.
| Last Split Date | 12/15/2025 |
| Split Ratio | 8:1 |
Scores
Beneficient posts an Altman Z-Score of -13.14, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -13.14 |